Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast

On Thursday, Cathie Wood's Ark Invest made a significant move by reducing its stake in Tesla, despite a recent bullish outlook on the company's potential in the autonomous taxi sector.

BenzingaJul 18 22:32 ET

Beam Therapeutics' (BEAM) CFO to Step Down, Stock Declines

Zacks Jul 16 10:35 ET

J.P. Morgan Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $45

J.P. Morgan analyst Eric Joseph maintains $Beam Therapeutics(BEAM.US)$ with a buy rating, and maintains the target price at $45.According to TipRanks data, the analyst has a success rate of 50.3%

Moomoo NewsJul 15 13:31 ET · Ratings

Beam Therapeutics Shares Fall After News of CFO Departure

By Zaeem Shoaib Beam Therapeutics shares fell Monday after the company said its finance chief would be leaving the company in August. Shares were down 8.8% to $24.52 in recent afternoon trading, and

WSJJul 15 13:16 ET

Beam Therapeutics Has Initiated A Search For A New CFO After Terry-Ann Burrell Shared Plans To Depart On August 9 To Join JPMorgan Chase

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that its chief financial officer, Terry-Ann Burrell, will

BenzingaJul 15 06:33 ET

Beam Therapeutics Has Initiated a Search for a Successor >BEAM

Beam Therapeutics Has Initiated a Search for a Successor >

Dow JonesJul 15 06:31 ET